Fifty percent of patients with mutant FLT3 achieved composite CR (CR plus CRi plus CR with incomplete platelet recovery) with an ORR (CR plus CRi plus morphologic leukemia-free state) of 88% in FLT3-mutated patients. The gene discussed is FLT3; the disease is leukemia.